OTLKW Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A

Watchlist

0.000
0.0000.00%

Close Dec 20 09:30 ET

0Market Cap0.00P/E (TTM)

Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A Key Stats

According to the latest financial report of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

FCF

Interested in knowing about Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A's free cash flow? The latest report shows it as -10.99M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A shows that the company's current ratio is 3.88, indicating healthy liquidity.

Currency: USD

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A, the quick ratio is 3.52, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

ROE

Want to learn more about the financial health of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A? The latest ROE figure is -54.14%, indicating that the company has stable profitability.

Currency: USD

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A, the total asset return on investment (ROA) is -28.50%.

Currency: USD

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A's latest financial report to see how their gross margin is doing - currently at --.

Currency: USD

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A, the net profit margin is -172.48%, which is a good sign for its profitability.

Currency: USD

Quarterly

Trending US Stocks